Trends in qualifying biomarkers in drug safety. Consensus of the 2011 meeting of the Spanish Society of Clinical Pharmacology.
In this paper we discuss the consensus view on the use of qualifying biomarkers in drug safety, raised within the frame of the XXIV meeting of the Spanish Society of Clinical Pharmacology held in Málaga (Spain) in October, 2011.The widespread use of biomarkers as surrogate endpoints is a go...
Main Authors: | José A.G. eAgúndez, Jaime edel Barrio, Teresa ePadró, Camilla eStephens, Magí eFarré, Raúl J Andrade, Lina eBadimon, Elena eGarcía-Martín, Gemma eVilahur, M Isabel eLucena |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2012-01-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fphar.2012.00002/full |
Similar Items
-
Genetic variations in drug-induced liver injury (DILI): resolving the puzzle
by: Camilla eStephens, et al.
Published: (2012-11-01) -
Clinical practice guidelines for translating pharmacogenomic knowledge to bedside. Focus on anticancer drugs.
by: José A G Agúndez, et al.
Published: (2014-08-01) -
Ischemia/reperfusion activates myocardial innate immune response: the key role of the toll-like receptor
by: Gemma eVilahur, et al.
Published: (2014-12-01) -
Towards a clinical practice guide in pharmacogenomics testing for functional polymorphisms of drug-metabolising enzymes. Gene/drug pairs and barriers perceived in Spain.
by: José A G Agúndez, et al.
Published: (2012-11-01) -
Bioinformatics and Pharmacogenomics in Drug Discovery and Development
by: Anyanwu, Chukwuma Eustace
Published: (2005)